Cytology plus HPV test don't improve detection rate

Article

Liquid-based cytology (LBC) plus human papillomavirus (HPV) testing in women led to a small decrease in the detection rate of cervical intraepithelial neoplasia grade 3 or worse (CIN3+) in a second screening round, compared to only LBC; but when the rounds were combined, using both methods didn?t detect more CIN3+ or CIN2+ than LBC alone, according to research published online June 18 in The Lancet Oncology.

Liquid-based cytology (LBC) plus human papillomavirus (HPV) testing in women led to a small decrease in the detection rate of cervical intraepithelial neoplasia grade 3 or worse (CIN3+) in a second screening round, compared to only LBC; but when the rounds were combined, using both methods didn’t detect more CIN3+ or CIN2+ than LBC alone, according to research published online June 18 in The Lancet Oncology.

Henry C. Kitchener, MD, of the University of Manchester in the United Kingdom, and colleagues analyzed data from 18,386 women who were randomly assigned to receive LBC and HPV testing in which the results were revealed and acted upon, and 6,124 women who received combined testing from which the HPV result was concealed. The main outcome was the rate of detection of CIN3+ in a second screening round conducted roughly 3 years later.

In the first round, the revealed and concealed groups had similar proportions with CIN3+ (1.27% and 1.31%, respectively), the researchers discovered. In the second round, both groups saw large drops in women with CIN3+ (0.25% and 0.47%, respectively). When the two rounds were combined, the authors note, co-testing did not identify a higher rate of women with CIN3+ or CIN2+ than LBC alone.

“Over two rounds this trial showed no evidence that LBC combined with HPV testing in primary cervical screening detected more CIN2 or CIN3+ than cytology alone. This summed effect over two rounds is relevant because screening relies on repeated rounds to achieve its sensitivity,” the authors conclude.

A co-author reported being an unpaid consultant for Hologic.

Kitchener HC, Almonte M, Thomson C, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncolog. 2009;10:672-682. doi: 10.1016/S1470-2045(09)70156-1.

Recent Videos
Expert discussions from the 2025 ACOG meeting | Image Credit: © stevengaertner - © stevengaertner - stock.adobe.com.
Trina Mansour, MD
Negative pressure wound therapy reduces c-section infections and costs | Image Credit: doctors.valleyhealth.com.
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Lisa Bayer, MD, MPH
Megan Wasson, DO, FACOG
Megan Cohen, MD, MPH, outlines 2024 CDC contraception guidelines | Image Credit: linkedin.com.
Wasson and Colak
Johanna Finkle, MD, weight loss specialist, OB/GYN, The University of Kansas Health System.
Navigating hormone therapy in high-risk menopause cases | Image Credit: © dhaj7-cepo.com.
© 2025 MJH Life Sciences

All rights reserved.